A New Governance Approach to Regulating Human Genome Editing

Area of Science:

• Genomic medicine and gene editing technologies.
• Bioethics and public policy in scientific advancement.
• International scientific governance and regulation.

Background:

• Genomic medicine, while promising, has had limited impact on daily practice.
• The goal of genomic medicine is to not only identify but also repair gene mutations.
• CRISPR and genome-editing technologies present potential solutions for repairing dangerous mutations.

Purpose of the Study:

• To identify and investigate practical, ethical, and policy considerations of human genome editing.
• To develop policy options for the governance of human genome editing.
• To monitor and analyze discussions and initiatives related to genome editing governance.

Main Methods:

• Multi-year, interdisciplinary project involving monitoring governmental and private groups.
• Observing scientific conferences and analyzing policy reports from national and international bodies.
• Interviewing diverse stakeholders, including scientists, ethicists, and policymakers.

Main Results:

• Identified prominent stakeholder concerns regarding human genome editing.
• Explored implications of these concerns for alternative governance models.
• Indicated that 'soft,' hybrid governance models involving multiple public and private stakeholders are promising.

Conclusions:

• Human genome editing necessitates urgent international governance discussions.
• Hybrid governance models, drawing from the 'new governance' paradigm, offer a practical path forward.
• Continued interdisciplinary research and stakeholder engagement are vital for effective policy development.